Journal Article

Minocycline-Ethylenediaminetetraacetate Lock Solution for the Prevention of Implantable Port Infections in Children with Cancer

Ioannis Chatzinikolaou, Theodore F. Zipf, Hend Hanna, Jan Umphrey, W. Mark Roberts, Robert Sherertz, Ray Hachem and Issam Raad

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 36, issue 1, pages 116-119
Published in print January 2003 | ISSN: 1058-4838
Published online January 2003 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/344952
Minocycline-Ethylenediaminetetraacetate Lock Solution for the Prevention of Implantable Port Infections in Children with Cancer

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

In this prospective cohort study, minocycline-ethylenediaminetetraacetate (M-EDTA) was used as a lock solution in indwelling ports inserted in 14 children with cancer. No port infections, thrombotic events, or other adverse events were observed, compared with 10 port infections that occurred in 48 control patients whose ports were flushed with heparin. M-EDTA is a promising lock solution in long-term catheters.

Journal Article.  2124 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.